(ACHC) Acadia Healthcare - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US00404A1097
ACHC: Psychiatric, Rehabilitation, Treatment, Recovery, Mental Health, Services
Acadia Healthcare Company Inc. (NASDAQ: ACHC), established in 2005 and headquartered in Franklin, Tennessee, is a prominent provider of behavioral healthcare services across the United States and Puerto Rico. The company operates a diverse network of facilities, including acute inpatient psychiatric units, residential recovery centers, eating disorder treatment facilities, and outpatient services, addressing a wide range of mental health and addiction recovery needs.
Investors may note that ACHC has strategically expanded through acquisitions and partnerships, enhancing its market position. With a market capitalization of approximately $3.88 billion, the company demonstrates moderate valuation with a trailing P/E of 13.69 and a forward P/E of 12.41, suggesting expectations of stable growth. The price-to-book ratio of 1.28 indicates a reasonable valuation relative to its assets, while the price-to-sales ratio of 1.24 reflects a competitive position in the healthcare facilities sector.
Acadias financial health is further highlighted by its revenue streams across various service lines, supporting profitability metrics in line with industry standards. The companys focus on a continuum of care positions it well to meet growing demand for behavioral health services, driven by increasing awareness and reduced stigma around mental health issues.
For fund managers, ACHCs stable cash flows from a diversified portfolio of facilities present an attractive investment proposition. The companys strategic initiatives aim to drive long-term growth, supported by a strong leadership team navigating industry trends and regulatory landscapes.
Additional Sources for ACHC Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ACHC Stock Overview
Market Cap in USD | 3,878m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Facilities |
IPO / Inception | 1994-03-04 |
ACHC Stock Ratings
Growth 5y | 6.71% |
Fundamental | 17.6% |
Dividend | 0.0% |
Rel. Strength Industry | -53.7 |
Analysts | 4.54/5 |
Fair Price Momentum | 32.70 USD |
Fair Price DCF | 6.80 USD |
ACHC Dividends
No Dividends PaidACHC Growth Ratios
Growth Correlation 3m | 47.6% |
Growth Correlation 12m | -78.3% |
Growth Correlation 5y | 53.9% |
CAGR 5y | 3.29% |
CAGR/Max DD 5y | 0.05 |
Sharpe Ratio 12m | -1.56 |
Alpha | -67.25 |
Beta | 0.64 |
Volatility | 34.29% |
Current Volume | 1325.7k |
Average Volume 20d | 979.9k |
As of February 22, 2025, the stock is trading at USD 39.65 with a total of 1,325,722 shares traded.
Over the past week, the price has changed by -3.43%, over one month by -10.64%, over three months by +2.75% and over the past year by -52.66%.
Neither. Based on ValueRay Fundamental Analyses, Acadia Healthcare is currently (February 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 17.64 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ACHC as of February 2025 is 32.70. This means that ACHC is currently overvalued and has a potential downside of -17.53%.
Acadia Healthcare has received a consensus analysts rating of 4.54. Therefor, it is recommend to buy ACHC.
- Strong Buy: 9
- Buy: 2
- Hold: 2
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, ACHC Acadia Healthcare will be worth about 36.9 in February 2026. The stock is currently trading at 39.65. This means that the stock has a potential downside of -6.83%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 61.4 | 54.8% |
Analysts Target Price | 61.4 | 54.8% |
ValueRay Target Price | 36.9 | -6.8% |